Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gpzide M 5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Ronak Laboratories

Salt Composition

Glipizide (5mg) + Metformin (500mg)

Overview Gpzide M 5mg/500mg Tablet

DiaBeta-Duo 5mg/500mg tablets are classified as antidiabetic agents. This dual-action medication, combining two active components, manages type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta-Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb impairment. DiaBeta-Duo is one element of a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle modifications are essential for effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are vital. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. DiaBeta-Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count, liver function tests) are recommended.

Primary Ingredients of Gpzide M 5mg/500mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Gpzide M 5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Gpzide M 5mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Gpzide M 5mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Gpzide M 5mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Diarrhea
  • Headache
  • Upper respiratory tract infection

How to use Gpzide M 5mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Gpzide M 5mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Gpzide M 5mg/500mg Tablet works:

Glipizide and Metformin, each 5mg and 500mg respectively, are combined in the Gpzide M tablet for the management of diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Gpzide M 5mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gpzide M 5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gpzide M 5mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gpzide M 5mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Gpzide M 5mg/500mg tablet use. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gpzide M 5mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For individuals with mild to moderate liver disease, initiation should involve a low Gpzide M 5mg/500mg tablet dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Gpzide M 5mg/500mg Tablet :

Should you forget to take your Gpzide M 5mg/500mg Tablet, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gpzide M 5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gpzide M 5mg/500mg Tablet

Gpzide M 5mg/500mg tablets combine glipizide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glipizide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gpzide M 5mg/500mg tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Gpzide M 5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always keep a readily available source of glucose, such as tablets, honey, or fruit juice, on hand.
Gpzide M 5mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention and discontinue Gpzide M 5mg/500mg Tablets if these symptoms occur.
Prolonged use of Gpzide M 5mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gpzide M 5mg/500mg Tablets are contraindicated in patients with allergies to any ingredient, those with moderate to severe kidney disease, and those with metabolic acidosis, including diabetic ketoacidosis.
Combining Gpzide M 5mg/500mg tablets with alcohol is unsafe. This combination may worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Gpzide M 5mg/500mg Tablet
11
MRP 14
21% off